Geneos Wealth Management’s Broadcom AVGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.1M Sell
51,899
-4,280
-8% -$1.41M 0.37% 58
2025
Q4
$19.4M Sell
56,179
-11,088
-16% -$3.97M 0.48% 47
2025
Q3
$22.2M Sell
67,267
-13,482
-17% -$4.14M 0.56% 34
2025
Q2
$22.3M Sell
80,749
-78,587
-49% -$17.1M 0.54% 37
2025
Q1
$26.7M Buy
159,336
+109,184
+218% +$23.1M 0.38% 58
2024
Q4
$11.6M Sell
50,152
-3,917
-7% -$724K 0.41% 49
2024
Q3
$9.33M Sell
54,069
-19,981
-27% -$3.2M 0.36% 63
2024
Q2
$11.9M Sell
74,050
-6,580
-8% -$922K 0.53% 41
2024
Q1
$10.7M Buy
80,630
+27,670
+52% +$3.43M 0.49% 43
2023
Q4
$5.91M Sell
52,960
-12,040
-19% -$1.14M 0.29% 78
2023
Q3
$5.4M Sell
65,000
-72,600
-53% -$6.29M 0.28% 88
2023
Q2
$11.9M Buy
137,600
+3,370
+3% +$240K 0.63% 30
2023
Q1
$8.61M Sell
134,230
-54,130
-29% -$3.26M 0.52% 35
2022
Q4
$10.5M Buy
188,360
+34,730
+23% +$1.74M 0.64% 25
2022
Q3
$6.82M Buy
153,630
+11,360
+8% +$580K 0.47% 39
2022
Q2
$6.8M Buy
142,270
+23,090
+19% +$1.3M 0.34% 61
2022
Q1
$7.5M Sell
119,180
-2,250
-2% -$134K 0.32% 63
2021
Q4
$8.08M Sell
121,430
-28,360
-19% -$1.59M 0.31% 65
2021
Q3
$7.3M Sell
149,790
-30
-0% -$1.46K 0.28% 69
2021
Q2
$7.01M Sell
149,820
-5,590
-4% -$259K 0.27% 75
2021
Q1
$7.09M Sell
155,410
-6,350
-4% -$294K 0.2% 117
2020
Q4
$7.46M Buy
161,760
+1,230
+0.8% +$48K 0.3% 69
2020
Q3
$5.73M Sell
160,530
-45,050
-22% -$1.51M 0.3% 74
2020
Q2
$6.32M Buy
205,580
+1,570
+0.8% +$43.9K 0.35% 67
2020
Q1
$4.71M Buy
204,010
+3,120
+2% +$87.9K 0.32% 70
2019
Q4
$6.36M Buy
200,890
+4,060
+2% +$123K 0.34% 71
2019
Q3
$5.4M Sell
196,830
-3,090
-2% -$87.9K 0.32% 78
2019
Q2
$5.75M Sell
199,920
-1,650
-0.8% -$48.1K 0.36% 67
2019
Q1
$6.06M Sell
201,570
-45,260
-18% -$1.23M 0.4% 56
2018
Q4
$6.26M Sell
246,830
-3,890
-2% -$91.8K 0.46% 44
2018
Q3
$6.19M Buy
250,720
+247,310
+7,252% +$5.55M 0.41% 52
2018
Q2
$82K Buy
+3,410
New +$83.6K 0.01% 850

Other funds holding AVGO

Geneos Wealth Management's AVGO Position: Q1 2026 in Review

Geneos Wealth Management reduced its Broadcom (AVGO) stake by 7.6% in Q1 2026, selling an estimated $1.41M and leaving 51,899 shares worth $16.1M. The position accounts for 0.37% of the portfolio, ranked #58.

Geneos Wealth Management first reported a position in AVGO in Q2 2018 and has held it in 32 quarters since. The position peaked at $26.7M in Q1 2025. 4,662 funds tracked by Wall St. Rank hold AVGO as of Q1 2026.

  • Geneos Wealth Management held 51,899 shares of Broadcom worth $16.1M as of Q1 2026.
  • Geneos Wealth Management sold 4,280 Broadcom shares in Q1 2026, an estimated $1.41M.
  • Broadcom made up 0.37% of Geneos Wealth Management's portfolio in Q1 2026, its #58 holding.
  • Geneos Wealth Management first reported a position in Broadcom in Q2 2018 and has held it in 32 quarters since.
  • Geneos Wealth Management's Broadcom position peaked at $26.7M in Q1 2025.
  • 4,662 funds tracked by Wall St. Rank held Broadcom as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.